FRUSCIO ROBERT

Landolfo, C., Froyman, W., Testa, A., Fischerova, D., Franchi, D., Yazbek, J., et al. (2026). Imaging in gynecological disease (29): clinical and ultrasound features of primary ovarian immature teratoma. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 67(1), 89-99 [10.1002/uog.70111]. Dettaglio

Apostol, A., Gronwald, J., Cybulski, C., Kim, R., Møller, P., Karlan, B., et al. (2026). Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2. JOURNAL OF CLINICAL ONCOLOGY, 44(10), 883-892 [10.1200/JCO-25-01648]. Dettaglio

Toss, A., Blondeaux, E., Tenedini, E., Bonamici, L., Graffeo, R., Livraghi, L., et al. (2026). Association between type and location of germline BRCA1/2 pathogenic or likely pathogenic variants with phenotype and prognosis in young patients with breast cancer: results from an international cohort study. ANNALS OF ONCOLOGY, 37(3), 364-377 [10.1016/j.annonc.2025.11.004]. Dettaglio

Becherini, C., Blondeaux, E., Delucchi, V., Visani, L., Kim, H., Coussy, F., et al. (2026). Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study. RADIOTHERAPY AND ONCOLOGY, 219(June 2026) [10.1016/j.radonc.2026.111523]. Dettaglio

Alviano, A., Pagni, F., Seminati, D., Casati, G., Jaconi, M., Fruscio, R., et al. (2026). Validation of QuANTUM-derived tumor cell fraction for molecular testing in high-grade serous tubo-ovarian carcinoma. NPJ PRECISION ONCOLOGY, 10(1) [10.1038/s41698-026-01414-0]. Dettaglio